About KHLORIS BIOSCIENCES, INC.
Khloris Biosciences is a biotechnology company focused on developing cancer vaccines and cell therapies using induced pluripotent stem cells (iPSCs). The company is also a leader in using iPSC-derived cardiomyocytes for cardiovascular disease treatments.
Development of cancer vaccines using patient-derived iPSCsResearch and application of iPSC-derived cardiomyocytes for cardiovascular disease treatmentDrug discovery and cell therapy development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to KHLORIS BIOSCIENCES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.